American College of Emergency Physicians

Last updated
American College of Emergency Physicians
AbbreviationACEP
Formation1968
Headquarters Irving, Texas
Region
United States of America
Membership (2020)
>38,000 members
Publication Annals of Emergency Medicine
Website www.acep.org
American College of Emergency Physicians American College of Emergency Physicians - 01.jpg
American College of Emergency Physicians

The American College of Emergency Physicians (ACEP) is a professional organization of emergency medicine physicians in the United States. ACEP publishes the Annals of Emergency Medicine and the Journal of the American College of Emergency Physicians Open (JACEP Open). [1]

Contents

ACEP is a partner of the National Foundation for Infectious Diseases (NFID). [2]

History

The organization was founded August 16, 1968, by eight physicians in Lansing, Michigan. [3] [4] [5] ACEP established the American Board of Emergency Medicine (ABEM) in 1976. [4]

COVID-19

During the COVID-19 pandemic, ACEP participated in a number of efforts to promote the uptake and acceptance of COVID-19 vaccines, including as a participant in the COVID-19 Vaccine Education and Equity Project led by the Alliance for Aging Research, HealthyWomen and the National Caucus and Center on Black Aging. [6]

In early 2021, ACEP received an $8,000 grant from Pfizer to fund a public service announcement on vaccine confidence. [7] On March 19, 2021, ACEP published a joint statement in support of COVID-19 vaccines alongside the American College of Medical Toxicology and the American Academy of Emergency Medicine. [8]

See also

Related Research Articles

<span class="mw-page-title-main">Pfizer</span> American multinational pharmaceutical and biotechnology corporation

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).

The American College of Preventive Medicine (ACPM) is an American non-profit organization focused on practice, research, publication, and teaching of evidence-based preventive medicine. It publishes the American Journal of Preventive Medicine, which is their official journal.

The American Academy of Environmental Medicine (AAEM), founded in 1965 as the Society for Clinical Ecology, is an international association of physicians and associated professionals interested in the clinical aspects of ecological or environmental illnesses, which is called clinical ecology. The academy aims for recognition of ecologic illness as a medical diagnosis.

The Canadian Association of Emergency Physicians (CAEP) is the professional association of emergency physicians in Canada. It is also known in French as Association Canadienne des Médecins d'Urgence (ACMU). The official journal of the CAEP is the Canadian Journal of Emergency Medicine.

AMCP is a professional organization representing the interests of pharmacists who practice in managed care settings. It publishes the Journal of Managed Care & Specialty Pharmacy.

<span class="mw-page-title-main">COVID-19 vaccine</span> Vaccine against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).

<span class="mw-page-title-main">Moderna COVID-19 vaccine</span> RNA COVID-19 vaccine

The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in humans aged six months, twelve years, or eighteen years and older. It provides protection against COVID-19, which is caused by infection by the SARS-CoV-2 virus. It is designed to be administered in two or three 0.5-mL doses given by intramuscular injection at an interval of at least 28 days apart.

<span class="mw-page-title-main">Uché Blackstock</span> American physician (born 1977)

Uché Blackstock is an American emergency physician and former associate professor of emergency medicine at the New York University School of Medicine. She is the founder and CEO of Advancing Health Equity, which has a primary mission to engage with healthcare and related organizations around bias and racism in healthcare with the goal of mobilizing for health equity and eradicating racialized health inequities. During the COVID-19 pandemic Blackstock used social media to share her experiences and concerns as a physician working on the front lines and on racial health disparities and inequities exposed by the pandemic. She is best known for her work amplifying the message on racial health inequities and her media appearances speaking on the COVID-19 pandemic. She has been featured on Meet the Press, PBS NewsHour, Slate and Forbes among others. Blackstock became a Yahoo! News Medical Contributor in June 2020.

<span class="mw-page-title-main">Pfizer–BioNTech COVID-19 vaccine</span> Type of vaccine for humans

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. It is authorized for use in humans to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) encoding a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial advice indicated that vaccination required two doses given 21 days apart, but the interval was later extended to up to 42 days in the US, and up to four months in Canada.

<span class="mw-page-title-main">Drew Weissman</span> American physician and immunologist (born 1959)

Drew Weissman is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).

<span class="mw-page-title-main">Barney S. Graham</span> American immunologist (born 1953)

Barney S. Graham is an American immunologist, virologist, and clinical trials physician.

<span class="mw-page-title-main">History of COVID-19 vaccine development</span> Scientific work to develop a vaccine for COVID-19

SARS-CoV-2, the virus that causes COVID-19, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. According to the Coalition for Epidemic Preparedness Innovations (CEPI), the geographic distribution of COVID‑19 vaccine development shows North American entities to have about 40% of the activity, compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.

<span class="mw-page-title-main">COVID-19 vaccination in Albania</span>

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

<span class="mw-page-title-main">Kieran Moore</span> Ontario Chief Medical Officer of Health

Kieran Michael Moore is a Canadian physician and public servant who serves as the current chief medical officer of health of Ontario. Prior to his appointment, he served as the medical officer of health for Kingston, Frontenac, Lennox and Addington from 2017 to 2021.

Onyema Eberechukwu Ogbuagu is an American-born infectious diseases physician, educator, researcher, and clinical trial investigator, who was raised and educated in Nigeria. He is an associate professor at Yale School of Medicine in New Haven, CT and is the director of the Yale AIDS Program clinical trials unit. His research contributions have focused on HIV/AIDS prevention and COVID-19 vaccination and treatment clinical trials. He switched his focus at the beginning of the 2019 COVID pandemic and participated as a principal investigator (PI) on the Pfizer-BioNtech COVID-19 vaccine trials and the Remdesivir SIMPLE trial in 2020 and 2021. In pursuit of his global health component of his career, Ogbuagu also supports postgraduate physician medical education programs in low and middle income countries in sub-Saharan Africa in Rwanda (2013–2018) and Liberia as well as HIV treatment programs in Liberia.

William C. Gruber is an American physician-scientist, pediatrician, and business executive. He is the senior vice president of Pfizer vaccine clinical research and development.

<span class="mw-page-title-main">John R. Mascola</span> American Physician-Scientist

John R. Mascola is an American physician-scientist, immunologist and infectious disease specialist. He was the director of the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ModeX Therapeutics.

Bisola Ojikutu is an American physician, disease specialist, and researcher. In July 2021, she was appointed as the executive director of the Boston Public Health Commission. Ojikutu is the fifth Commissioner of Public Health for the City of Boston and the first Black person to permanently hold this position. She currently serves on the Cabinet of Mayor Michelle Wu.

Yvette Calderon is an American physician who is Chair and Professor of Emergency Medicine in the Icahn School of Medicine at Mount Sinai. Her research has focused on health disparities in Manhattan, with a particular focus on HIV and hepatitis C. She was elected to the National Academy of Medicine in 2022.

References

  1. "JACEP Open". Wiley Online Library.
  2. "NFID Partner Organizations". National Foundation for Infectious Diseases . 2022-01-06. Archived from the original on 2022-07-16. Retrieved 2023-05-11.
  3. "History". AAEM - American Academy of Emergency Medicine. Retrieved 2022-10-25.
  4. 1 2 Suter, Robert E. (2012). "Emergency medicine in the United States: a systemic review". World Journal of Emergency Medicine. 3 (1): 5–10. doi:10.5847/wjem.j.issn.1920-8642.2012.01.001. ISSN   1920-8642. PMC   4129827 . PMID   25215031.
  5. "A Brief History of Emergency Medicine Residency Training". Emergency Medicine Residents' Association. Retrieved 2022-10-25.
  6. "About The Project". COVID-19 Vaccine Education and Equity Project. Archived from the original on 2022-07-07. Retrieved 2023-05-11.
  7. "US Medical, Scientific, Patient and Civic Organization Funding Report: Q1-Q2 2021" (PDF). Pfizer. 2021-09-27. Archived (PDF) from the original on 2023-05-03. Retrieved 2023-05-11.
  8. American College of Medical Toxicology, Board of Directors; American Academy of Emergency Medicine; American College of Emergency Physicians (2021-03-19). "ACMT/AAEM/ACEP Joint Statement in Support of COVID-19 Vaccines" (PDF). American College of Emergency Physicians. Archived (PDF) from the original on 2023-05-11. Retrieved 2023-05-11.